Pharmacokinetic metrics CL, Vd and F [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2017-05-06 14:14 (2539 d 23:56 ago) – Posting: # 17309
Views: 10,045

Hi MMW,

❝ As per the Guideline, for CFDA submissions, …


This one (page 17)?

F = 100×AUCT/AUCR.

If the drug exhibits linear PK and different doses are administered a correction is suggested

F = 100×(AUCT×DR)/(AUCR×DT).


❝ … pharmacokinetic parameters CL, Vd and F needs to be submitted.


<nitpicking>

pharmacokinetic modeling → PK parameters
noncompartmental analysis → PK metrics

</nitpicking>

❝ Can we calculate these parameters in Phoenix software?


If you have a Phoenix/WinNonlin license, please RTFM. ;-)

To calculate ƒ (absolute bioavailability after an extravascular dose) you need a crossover study with EV vs. IV doses. Better is simultaneous administration of EV and stable isotope labeled IV – which requires cGMP of the IV dose (that’s a big obstacle). Then

ƒ = (AUC∞,EV×DIV)/(AUC∞,IV×DEV) and
F (%) = 100ƒ.

Note that ƒ calculated from a crossover study assumes constant inter-occasion clearances, which might not be correct (especially for highly variable drugs*).
CL and Vd are only accessible after an intravenous dose, where

CL = D/AUC and
Vd = D/C0.

Without ƒ (i.e., only EV dosing) you get just CL/ƒ and Vd/ƒ, which IMHO is of limited value since ƒ is unknown. Both are given in the standard output of Phoenix/WinNonlin. Report them to make the CFDA happy (irrelevant in BE) but please not as CL and V.



Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,664 registered users;
77 visitors (0 registered, 77 guests [including 8 identified bots]).
Forum time: 14:10 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5